Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by delivering novel therapies that address areas of high unmet need in RAS pathway-driven cancers. At Verastem Oncology, it takes our diversity of backgrounds, expertise, perspectives, and skills to find the answers that patients need, but don’t have—yet. To join our team or for more information, please visit www.verastem.com. Twitter: @VerastemOncolog
View Top Employees from Verastem OncologyWebsite | https://www.verastem.com |
Ticker | VSTM |
Revenue | $17 million |
Funding | $449 million |
Employees | 87 (83 on RocketReach) |
Founded | 2010 |
Address | 117 Kendrick Street Suite 500, Needham, Massachusetts 02494, US |
Phone | (781) 292-4200 |
Technologies |
JavaScript,
HTML,
PHP
+46 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Biopharma, Pharmaceuticals, Biotechnology, Healthcare, Health Care, Science and Engineering, Pharmaceutical |
Competitors | Biokine Therapeutics Ltd., Catabasis Pharmaceuticals, Inc., Kura Oncology, Inc., Onconova Therapeutics, Xenon Pharmaceuticals Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Verastem Oncology employee's phone or email?
The Verastem Oncology annual revenue was $17 million in 2024.
Brian Stuglik is the CEO of Verastem Oncology.
83 people are employed at Verastem Oncology.
Verastem Oncology is based in Needham, Massachusetts.
The NAICS codes for Verastem Oncology are [32, 32541, 325, 3254].
The SIC codes for Verastem Oncology are [283, 28].